These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15035897)

  • 1. Circadian timing in cancer treatment: the biological foundation for an integrative approach.
    Lis CG; Grutsch JF; Wood P; You M; Rich I; Hrushesky WJ
    Integr Cancer Ther; 2003 Jun; 2(2):105-11. PubMed ID: 15035897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timing is everything.
    Block KI
    Integr Cancer Ther; 2003 Jun; 2(2):103-4. PubMed ID: 15035896
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic colorectal cancer: the European Organisation for Research and Treatment of Cancer Chronotherapy Group.
    Giacchetti S; Bjarnason G; Garufi C; Genet D; Iacobelli S; Tampellini M; Smaaland R; Focan C; Coudert B; Humblet Y; Canon JL; Adenis A; Lo Re G; Carvalho C; Schueller J; Anciaux N; Lentz MA; Baron B; Gorlia T; Lévi F;
    J Clin Oncol; 2006 Aug; 24(22):3562-9. PubMed ID: 16877722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose intensity and hematologic toxicity in older cancer patients receiving systemic chemotherapy.
    Shayne M; Culakova E; Poniewierski MS; Wolff D; Dale DC; Crawford J; Lyman GH
    Cancer; 2007 Oct; 110(7):1611-20. PubMed ID: 17705197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of circadian clocks for the rhythmic delivery of cancer therapeutics.
    Lévi F; Focan C; Karaboué A; de la Valette V; Focan-Henrard D; Baron B; Kreutz F; Giacchetti S
    Adv Drug Deliv Rev; 2007 Aug; 59(9-10):1015-35. PubMed ID: 17692427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the natural history of nonsmall cell lung cancer (NSCLC)--comparison of outcomes and characteristics in patients with advanced NSCLC entered in Eastern Cooperative Oncology Group trials before and after 1990.
    Wakelee HA; Bernardo P; Johnson DH; Schiller JH
    Cancer; 2006 May; 106(10):2208-17. PubMed ID: 16604529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic options for elderly patients with advanced non-small cell lung cancer.
    Avery EJ; Kessinger A; Ganti AK
    Cancer Treat Rev; 2009 Jun; 35(4):340-4. PubMed ID: 19155139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of axillary lymph node-negative, estrogen receptor-negative breast cancer: updated findings from National Surgical Adjuvant Breast and Bowel Project clinical trials.
    Fisher B; Jeong JH; Anderson S; Wolmark N
    J Natl Cancer Inst; 2004 Dec; 96(24):1823-31. PubMed ID: 15601638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronopharmacokinetics of oral tegafur and uracil in colorectal cancer patients.
    Etienne-Grimaldi MC; Cardot JM; François E; Renée N; Douillard JY; Gamelin E; Milano G
    Clin Pharmacol Ther; 2008 Mar; 83(3):413-5. PubMed ID: 17637782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting angiogenesis with integrative cancer therapies.
    Yance DR; Sagar SM
    Integr Cancer Ther; 2006 Mar; 5(1):9-29. PubMed ID: 16484711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy for prostate cancer in senior adults: are we treating the elderly or the frail?
    Bellmunt J
    Eur Urol; 2009 Jun; 55(6):1310-2. PubMed ID: 18778888
    [No Abstract]   [Full Text] [Related]  

  • 12. Cancer chemoprevention: scientific promise, clinical uncertainty.
    Sporn MB; Liby KT
    Nat Clin Pract Oncol; 2005 Oct; 2(10):518-25. PubMed ID: 16205771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dense adjuvant chemotherapy in early breast cancer patients: results from a randomized trial.
    Venturini M; Del Mastro L; Aitini E; Baldini E; Caroti C; Contu A; Testore F; Brema F; Pronzato P; Cavazzini G; Sertoli MR; Canavese G; Rosso R; Bruzzi P
    J Natl Cancer Inst; 2005 Dec; 97(23):1724-33. PubMed ID: 16333028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple dietary antioxidants enhance the efficacy of standard and experimental cancer therapies and decrease their toxicity.
    Prasad KN
    Integr Cancer Ther; 2004 Dec; 3(4):310-22. PubMed ID: 15523102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival impact of integrative cancer care in advanced metastatic breast cancer.
    Block KI; Gyllenhaal C; Tripathy D; Freels S; Mead MN; Block PB; Steinmann WC; Newman RA; Shoham J
    Breast J; 2009; 15(4):357-66. PubMed ID: 19470134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MAX2--a convenient index to estimate the average per patient risk for chemotherapy toxicity; validation in ECOG trials.
    Extermann M; Bonetti M; Sledge GW; O'Dwyer PJ; Bonomi P; Benson AB
    Eur J Cancer; 2004 May; 40(8):1193-8. PubMed ID: 15110883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interest of chronotherapy in multidisciplinary management of oesophageal and gastric cancers].
    Focan C; Kreutz F; Longrée L; Graas MP; Moeneclaey N; Demolin G; Focan-Henrard D
    Pathol Biol (Paris); 2007; 55(3-4):181-5. PubMed ID: 17418504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Convection-enhanced delivery for treatment of brain tumors.
    Ferguson SD; Foster K; Yamini B
    Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S79-85. PubMed ID: 18076322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study.
    Hermida RC
    Chronobiol Int; 2007; 24(4):749-75. PubMed ID: 17701685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trial.
    Leonard RC; Lind M; Twelves C; Coleman R; van Belle S; Wilson C; Ledermann J; Kennedy I; Barrett-Lee P; Perren T; Verrill M; Cameron D; Foster E; Yellowlees A; Crown J;
    J Natl Cancer Inst; 2004 Jul; 96(14):1076-83. PubMed ID: 15265969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.